Select Bibliography

Filter by any of these (after searching):

Laumann, Kristina

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 17 items

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

Advani, Anjali S. , Larsen, Eric , Laumann, Kristina ... - - Blood Adv - 2021

Manuscript - Secondary - Primary - Leukemia - CALGB-10403 , COG-AALL0232

Outcome for Pediatric Acute Promyelocytic Leukemia Patients at Children’s Oncology Group Sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)

Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - - Pediatr Blood Cancer - 2019

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710

A Comparison of Outcomes between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance)

Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - ASH - Blood - 2014

Abstract - Secondary-not-in-original - Primary - Leukemia - Alliance-9710

Effect of young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance)

Kutny, Matthew A. , Gregory, John , Geyer, Susan , Laumann, Kristina ... - ASH - Blood - 2014

Abstract - Secondary-not-in-original - Primary - Leukemia - Alliance-9710

Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

Larson, Richard A. , Mandrekar, Sumithra J. , Huebner, Lucas J. ... - - Leukemia - 2021

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-10603

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Mantha, Simon , Goldman, Debra A. , Devlin, Sean M. , Lee, Ju-Whei ... - - Blood - 2017

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Marcucci, Guido , Geyer, Susan , Laumann, Kristina , Zhao, Weiqiang ... - - Blood Adv - 2020

Manuscript - Primary - Primary - Leukemia - CALGB-10801 , CALGB-20202

Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype

Poiré, Xavier , Moser, Barry K. , Gallagher, Robert E. ... - - Leuk Lymphoma - 2014

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Roboz, Gail J. , Mandrekar, Sumithra J. , Desai, Pinkal ... - - Blood Adv - 2018

Manuscript - Primary - Primary - Leukemia - CALGB-11002

Phase II Trials of Single Agent Anti-VEGF Therapy for Patients with Chronic Lymphocytic Leukemia (CLL)

Shanafelt, Tait , Zent, Clive , Byrd, John , Erlichman, Charles ... - - Leuk Lymphoma - 2010

Manuscript - Primary - Primary - Leukemia - NCCTG-N048F , NCCTG-N0683

An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia

Stock, Wendy , Diouf, Barthelemy , Crews, Kristine R. , Pei, Deqing ... - - Clin Pharmacol Ther - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-10102 , CALGB-10403 , CALGB-19802 , CALGB-9862

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Stock, Wendy , Luger, Selina M. , Advani, Anjali S. , Yin, Jun ... - - Blood - 2019

Manuscript - Primary - Primary - Leukemia - CALGB-10403

Favorable outcomes for adolescents and young adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early results of US Intergroup trial CALGB 10403 (Alliance)

Stock, Wendy , Luger, Selina , Advani, Anjali , Geyer, Susan ... - ASH - Blood - 2014

Abstract - Primary - Preliminary - Leukemia - CALGB-10403

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

Stone, Richard M. , Mandrekar, Sumithra J. , Sanford, Ben L. ... - - N Engl J Med - 2017

Manuscript - Primary - Primary - Leukemia - CALGB-10603

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001

Uy, Geoffrey L. , Mandrekar, Sumithra J. , Laumann, Kristina ... - - Blood Adv - 2017

Manuscript - Primary - Primary - Leukemia - CALGB-11001

Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults With FLT3-ITD Mutated AML (Alliance C11001).

Uy, Geoffrey L. , Mandrekar, Sumithra , Laumann, Kristina ... - ASH - Blood - 2015

Abstract - Primary - Primary - Leukemia - CALGB-11001

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance)

Vij, Ravi , Le-Rademacher, Jennifer , Laumann, Kristina , Hars, Vera ... - - Biol Blood Marrow Transplant - 2019

Manuscript - Primary - Primary - Transplant - CALGB-100801